iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBIO iBio Inc.

盘前交易 09-01 08:05:48 EDT

1.27

-0.09

-6.62%

盘前1.30

+0.03+2.36%

07:51 EDT

最高1.37	最低1.25	成交量87.58万
今开1.37	昨收1.36	日振幅8.82%
总市值8,167万	流通市值6,288万	总股本6,431万
成交额115.11万	换手率1.77%	流通股本4,951万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBIO","market":"US","secType":"STK","nameCN":"iBio Inc.","latestPrice":1.27,"timestamp":1788206400000,"preClose":1.36,"halted":0,"volume":875831,"hourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.27,"latestTime":"07:51 EDT","volume":1379,"amount":1761.267074,"timestamp":1788263479506,"change":0.03,"changeRate":0.023622,"amplitude":0.03937},"delay":0,"changeRate":-0.06617647058823535,"floatShares":49511300,"shares":64307256,"eps":-0.32,"marketStatus":"盘前交易","change":-0.09,"latestTime":"09-01 08:05:48 EDT","open":1.37,"high":1.37,"low":1.25,"amount":1151077.8828713999,"amplitude":0.088235,"askPrice":1.31,"askSize":100,"bidPrice":1.17,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-0.32,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1294117200000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.27,"latestTime":"07:51 EDT","volume":1379,"amount":1761.267074,"timestamp":1788263479506,"change":0.03,"changeRate":0.023622,"amplitude":0.03937},"postHourTrading":{"tag":"盘后","latestPrice":1.3192,"preClose":1.27,"latestTime":"19:53 EDT","volume":3793,"amount":4931.6987,"timestamp":1788220393689,"change":0.0492,"changeRate":0.03874,"amplitude":0.044173},"volumeRatio":2.0773073461815508,"impliedVol":5.1303,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/IBIO","defaultTab":"news","newsList":[{"id":"1175700411","title":"iBio强化临床领导层，任命内分泌专家Molly Carr为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1175700411","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175700411?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:01","pubTimestamp":1785841280,"startTime":"0","endTime":"0","summary":"iBio公司（iBio Inc.）如今正大力强化其临床领导团队。公司近日宣布，任命内分泌学专家Molly Carr博士担任首席医疗官一职。这一战略举措，旨在进一步提升其临床开发的专业深度与执行能力。\nMolly Carr的加入，被视作iBio发展进程中的关键一步。她不仅拥有深厚的医学背景，更在内分泌领域积累了丰富的临床经验。作为新任首席医疗官，她将负责监督公司的临床开发项目，并主导相关战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132883856","title":"iBio宣布单剂量IBIO-610在肥胖非人灵长类动物研究中实现近完全活性激活素E抑制，效果持续八周","url":"https://stock-news.laohu8.com/highlight/detail?id=1132883856","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132883856?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:06","pubTimestamp":1782903981,"startTime":"0","endTime":"0","summary":"iBio Inc. 公布了一项研究结果，显示在肥胖非人灵长类动物模型中，单次施用候选药物IBIO-610可在长达八周的时间内，实现近乎完全的活性激活素E抑制。该数据揭示了该疗法在靶向这一特定通路方面具有持久的药理活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106176872","title":"iBio Inc. 迈入临床阶段：首例肥胖成人患者接受 Ibio-600 一期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1106176872","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106176872?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:02","pubTimestamp":1780398121,"startTime":"0","endTime":"0","summary":"iBio Inc. 迎来关键里程碑，其针对肥胖成人患者的 Ibio-600 一期临床试验已完成首例受试者给药，标志着公司正式迈入临床阶段公司行列。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189029326","title":"iBio将公布针对射血分数保留型心力衰竭相关肺动脉高压的心肺项目最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1189029326","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189029326?lang=zh_cn&edition=full","pubTime":"2026-03-17 04:34","pubTimestamp":1773693276,"startTime":"0","endTime":"0","summary":"iBio Inc.宣布将就其心肺治疗项目的最新进展进行披露，该项目主要聚焦于射血分数保留型心力衰竭相关的肺动脉高压领域。此次更新将涵盖该项目的研发进程、阶段性成果以及未来发展方向。肺动脉高压合并心力衰竭是心血管疾病中的复杂病症，其治疗手段有限，市场潜力巨大。该项目的推进体现了iBio在心血管和肺部疾病领域的战略布局。未来，iBio将继续公布该项目的关键节点信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136230089","title":"iBio发布IBIO-610治疗肥胖非人灵长类动物的临床前体成分数据，该药物有望成为首个脂肪选择性减重疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1136230089","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136230089?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:04","pubTimestamp":1773054294,"startTime":"0","endTime":"0","summary":"iBio公司近日公布了其候选药物IBIO-610在肥胖非人灵长类动物模型中取得的临床前体成分数据。这项研究聚焦于IBIO-610作为一种潜在首创疗法的效果，该疗法旨在实现脂肪选择性减重，标志着公司在代谢疾病治疗领域的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517116539","title":"Ibio, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517116539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517116539?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:39","pubTimestamp":1741271983,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时39分，Ibio, Inc.股票出现波动，股价急速跳水5.21%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1137.52%、233.04%、55.06%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为31.46%、30.53%、23.12%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223944abeb7a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223944abeb7a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517410943","title":"Ibio, Inc.盘中异动 股价大涨6.66%报6.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517410943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185059,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Ibio, Inc.股票出现波动，股价急速拉升6.66%。截至发稿，该股报6.35美元/股，成交量3.6554万股，换手率0.37%，振幅0.00%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059963adc07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059963adc07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516347676","title":"Ibio, Inc.盘中异动 早盘股价大涨6.00%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516347676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516347676?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012470,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Ibio, Inc.股票出现异动，股价急速上涨6.00%。截至发稿，该股报6.18美元/股，成交量14.6236万股，换手率1.48%，振幅8.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514731543","title":"Ibio, Inc.盘中异动 早盘大幅下挫5.15%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514731543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514731543?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:56","pubTimestamp":1740754616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Ibio, Inc.股票出现波动，股价大幅跳水5.15%。截至发稿，该股报4.79美元/股，成交量27.218万股，换手率2.76%，振幅7.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514838859","title":"Ibio, Inc.盘中异动 股价大涨7.20%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514838859?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580409,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Ibio, Inc.股票出现波动，股价急速拉升7.20%。截至发稿，该股报4.17美元/股，成交量14.0798万股，换手率1.43%，振幅5.66%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223329abdded67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223329abdded67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514900770","title":"Ibio, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514900770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514900770?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494666,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Ibio, Inc.股票出现异动，股价快速拉升5.23%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为855.06%、620.78%、532.76%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224426962ff597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224426962ff597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727532","title":"Ibio, Inc.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727532?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Ibio, Inc.股票出现波动，股价大幅上涨5.17%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为52.60%、46.77%、24.53%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Gossamer Bio, Inc.，振幅分别为92.70%、21.42%、14.69%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512644271","title":"Ibio, Inc.盘中异动 早盘急速拉升6.41%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512644271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512644271?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:06","pubTimestamp":1739894765,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时06分，Ibio, Inc.股票出现波动，股价快速上涨6.41%。截至发稿，该股报3.65美元/股，成交量10.9246万股，换手率1.11%，振幅5.25%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000605988a0e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000605988a0e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511521300","title":"Ibio, Inc.盘中异动 早盘股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511521300?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:13","pubTimestamp":1739459599,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时13分，Ibio, Inc.股票出现异动，股价大幅跳水5.57%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1752.95%、1117.32%、140.15%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、32.86%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231319a244b4d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231319a244b4d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510538740","title":"Ibio, Inc.盘中异动 早盘股价大跌6.14%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510538740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510538740?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Ibio, Inc.股票出现波动，股价大幅跳水6.14%。截至发稿，该股报3.21美元/股，成交量1.6733万股，换手率0.17%，振幅1.61%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223215a241fb55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223215a241fb55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","OCEA","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162731855","title":"iBio 第二季度每股收益 $(0.48) 未能达到预期 $(0.32)，销售额为 $200.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=1162731855","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162731855?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:26","pubTimestamp":1739222778,"startTime":"0","endTime":"0","summary":"iBio  报告其季度每股亏损 $，未能达到分析师共识预期的 $，差距为 50%。这相比去年同期每股亏损 $ 增长了 80.17%。该公司本季度报告销售额为 $200.00千美元。以上内容来自Benzinga Earnings专栏，原文如下：iBio  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 50 percent. This is a 80.17 percent increase over losses of $ per share from the same period last year.  The company reported $200.00 thousand in sales this quarter.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"iBio 第二季度每股收益 $(0.48) 未能达到预期 $(0.32)，销售额为 $200.00K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509256848","title":"Ibio, Inc.盘中异动 急速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509256848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509256848?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:37","pubTimestamp":1738787836,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时37分，Ibio, Inc.股票出现波动，股价快速上涨5.35%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为2.38%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4694.80%、2439.13%、1782.57%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、96.79%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043716987bb513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043716987bb513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509493643","title":"Ibio, Inc.盘中异动 下午盘急速上涨5.11%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509493643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509493643?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:17","pubTimestamp":1738696620,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时17分，Ibio, Inc.股票出现波动，股价快速拉升5.11%。截至发稿，该股报3.29美元/股，成交量18.7977万股，换手率2.00%，振幅5.43%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205031700abc25c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205031700abc25c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506512077","title":"Ibio, Inc.盘中异动 股价大跌5.37%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506512077?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:11","pubTimestamp":1738077084,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时11分，Ibio, Inc.股票出现异动，股价大幅下跌5.37%。截至发稿，该股报2.82美元/股，成交量9.1419万股，换手率0.97%，振幅7.44%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231124a23277b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231124a23277b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506588869","title":"Ibio, Inc.盘中异动 急速下跌5.21%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506588869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506588869?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:21","pubTimestamp":1737998518,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时21分，Ibio, Inc.股票出现异动，股价急速下挫5.21%。截至发稿，该股报2.91美元/股，成交量16.5684万股，换手率1.76%，振幅6.19%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280121599874ca31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280121599874ca31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ibioinc.com","stockEarnings":[{"period":"1week","weight":-0.1056},{"period":"1month","weight":-0.0929},{"period":"3month","weight":-0.2784},{"period":"6month","weight":-0.5512},{"period":"1year","weight":0.5531},{"period":"ytd","weight":-0.342}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1196},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.1248}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iBio, Inc.于2008年4月17日根据特拉华州法律注册成立，名称为iBioPharma, Inc.，2008年7月25日与新泽西州的Biotechnologies, Inc.合并，并于2009年8月10日更名为iBio, Inc.。iBio是一家临床前阶段的生物技术公司，利用人工智能（AI）的力量开发精准抗体。该公司的专有技术堆栈旨在通过采用AI引导的表位指导和单克隆抗体（mAb）优化来最大限度地降低下游开发风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.132537},{"month":2,"riseRate":0.625,"avgChangeRate":0.661576},{"month":3,"riseRate":0.4375,"avgChangeRate":0.11465},{"month":4,"riseRate":0.25,"avgChangeRate":-0.132363},{"month":5,"riseRate":0.375,"avgChangeRate":-0.046566},{"month":6,"riseRate":0.5,"avgChangeRate":0.982354},{"month":7,"riseRate":0.1875,"avgChangeRate":-0.055478},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.053256},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.043607},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.012402},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.143238},{"month":12,"riseRate":0.133333,"avgChangeRate":-0.108408}],"exchange":"NASDAQ","name":"iBio Inc.","nameEN":"iBio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iBio Inc.(IBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iBio Inc.,IBIO,iBio Inc.股票,iBio Inc.股票老虎,iBio Inc.股票老虎国际,iBio Inc.行情,iBio Inc.股票行情,iBio Inc.股价,iBio Inc.股市,iBio Inc.股票价格,iBio Inc.股票交易,iBio Inc.股票购买,iBio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iBio Inc.(IBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}